No Products in the Cart
The U.S. Food and Drug Administration (FDA) recognized cannabidiol as a medicine for the first time on June 25, 2018 for the treatment of two severe pediatric seizure disorders, Lennox-Gastaut syndrome and Dravet syndrome. It later was approved by the agency to help treat seizures associated with tuberous sclerosis complex.
Someone purchsed a
